Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 0.6 mg/ml (equivalent: salbutamol, qty 0.5 mg/ml) - injection, solution - excipient ingredients: sodium chloride; sulfuric acid; water for injections - indications as at 3rd december 2002: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - salbutamol sulfate, quantity: 6 mg/ml (equivalent: salbutamol, qty 5 mg/ml) - inhalation - excipient ingredients: purified water; benzalkonium chloride; sulfuric acid - indications as at 1st february 1999: for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise-induced asthma or in other situations known to induce bronchospasm.

Australia - English - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - salbutamol sulfate -

Australia - English - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - salbutamol sulfate -

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - salbutamol sulfate -

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - salbutamol sulfate -

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - salbutamol sulfate, quantity: 6 mg (equivalent: salbutamol, qty 5 mg) - inhalation, conventional - excipient ingredients: sulfuric acid; water for injections; sodium chloride - for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise induced asthma or in other situations known to induce bronchospasm.

Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - salbutamol sulfate, quantity: 3 mg (equivalent: salbutamol, qty 2.5 mg) - inhalation, conventional - excipient ingredients: water for injections; sulfuric acid; sodium chloride - for the relief of bronchospasm in patients with asthma or chronic obstructive pulmonary disease, and for acute prophylaxis against exercise induced asthma or in other situations known to induce bronchospasm.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - salbutamol -

Ireland - English - HPRA (Health Products Regulatory Authority)

neutec inhaler ireland limited - salbutamol sulfate - nebuliser solution - salbutamol